BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Mar 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-03-28

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-28	Common Stock	M	1000	$17.86	Acquired	287031	Direct
2018-03-28	Common Stock	M	1000	$14.39	Acquired	288031	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-28	Stock Option (Right to buy Common Stock)	$17.86	M	1000	Disposed	2018-12-16	Common Stock (1000)	Direct
2018-03-28	Stock Option (Right to buy Common Stock)	$14.39	M	1000	Disposed	2019-05-11	Common Stock (1000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	182201	Indirect

Footnotes

F1: Reflects the number of options outstanding after the transactions from this specific stock option grant.